Takashi Kishimoto
Nessuna posizione attualmente
Patrimonio netto: 146 455 $ in data 31/03/2024
Profilo
Takashi Kei Kishimoto worked as a Senior Director-Inflammation Research at Millennium Pharmaceuticals, Inc. from 1999 to 2006.
He then worked as an Associate Director-Research at Boehringer Ingelheim Corp.
before becoming the Vice President-Discovery Research at Momenta Pharmaceuticals, Inc. from 2006 to 2011.
He then became the Chief Scientific Officer at Selecta Biosciences, Inc. in 2011, where he worked until 2023.
He also worked as a Vice President-Research at Momenta Corp.
Dr. Kishimoto holds a doctorate degree from Harvard University and an undergraduate degree from New College of Florida.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
0.14% | 31/05/2023 | 225 316 ( 0.14% ) | 146 455 $ | 31/03/2024 |
Precedenti posizioni note di Takashi Kishimoto
Società | Posizione | Fine |
---|---|---|
CARTESIAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 13/11/2023 |
MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2011 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2006 |
Momenta Corp. | Chief Tech/Sci/R&D Officer | - |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Chief Tech/Sci/R&D Officer | - |
Formazione di Takashi Kishimoto
Harvard University | Doctorate Degree |
New College of Florida | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Momenta Corp. |
- Borsa valori
- Insiders
- Takashi Kishimoto